Creative Planning’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-25,000
Closed -$7K 2236
2018
Q2
$7K Hold
25,000
﹤0.01% 1969
2018
Q1
$17K Sell
25,000
-50,000
-67% -$4.8M ﹤0.01% 1905
2017
Q4
$77K Buy
75,000
+25,000
+50% +$2.82M ﹤0.01% 1756
2017
Q3
$20K Buy
50,000
+48,000
+2,400% +$6.54M ﹤0.01% 1837
2017
Q2
$1K Hold
2,000
﹤0.01% 4583
2017
Q1
$5K Sell
2,000
-1,600
-44% -$191K ﹤0.01% 4016
2016
Q4
$9K Buy
3,600
+1,200
+50% +$134K ﹤0.01% 3658
2016
Q3
$4K Hold
2,400
﹤0.01% 4051
2016
Q2
$10K Buy
+2,400
New +$248K ﹤0.01% 3288

Other funds holding CELG

Creative Planning's CELG Position: Q4 2019 in Review

Creative Planning sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 86,317 shares — an estimated $8.57M sold.

Creative Planning first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $22M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Creative Planning reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Creative Planning sold 86,317 Celgene Corp shares in Q4 2019, an estimated $8.57M.
  • Creative Planning first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Creative Planning's Celgene Corp position peaked at $22M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.